NATIONAL
HEALTHCARE 2023
Blokhin National Medical Research Centre of Oncology - tour ‘Achievements of and Prospects for Paediatric Oncology’
- 30.11.2023
- 11:00–12:00
- 23, Kashirskoye Shosse, Moscow, enter opposite the fountain, hall of the 1st floor of the main building
- Date of the last day of registration for the tour: 11/28/2023 for Russian citizens, 11/23/2023 for foreign citizens
Description of the tour ‘Achievements of and Prospects for Paediatric Oncology’
The Durnov Research Institute of Paediatric Oncology and Haematology is a major paediatric oncology and haematology clinic. It combines the leading achievements of surgical and medicinal treatment of children. The clinic is a leader in cell therapy. Each year, more than 1,200 primary patients are admitted to the research institute, while the number of patients treated exceeds 8,000. The clinic annually performs up to 200 bone marrow transplants. The clinic is unique in terms of many of its technologies (organ-preserving treatment, high-dose therapy).
Route:
Presentation of information about the Blokhin National Medical Research Centre of Oncology and the Durnov Research Institute of Paediatric Oncology and Haematology on the 1st floor (hall)
Visit to the Resuscitation and Intensive Care Unit (5th floor, elevator)
Visit to the Early Childhood Unit (3rd floor, elevator)
Visit to the school of the ‘Learn and Know’ project
Return to the 1st floor hall
All participants need lists in advance.
Foreign citizens need to submit their full name, place of work, and copies of their passports for approval in the security departments a week in advance.
All participants must have a passport with them.
Blokhin National Medical Research Centre of Oncology of the Ministry of Health of the Russian Federation is the largest oncology clinic in Russia and Europe and one of the largest oncology clinics in the world. Its arsenal includes the all the latest equipment and advanced techniques for diagnosing and treating cancer.
Our goal is to continuously improve the quality and accessibility of cancer care. To achieve this goal, we are working to improve the medical care system and introduce the latest technologies.
The centre includes five units:
• Trapeznikov Research Institute of Clinical Oncology with 900 beds
• Research Institute of Paediatric Oncology and Haematology with 299 beds
• Research Institute of Clinical and Experimental Radiology with 101 beds
• Research Institute of Carcinogenesis with 16 laboratories
• Research Institute for Experimental Diagnostics and Therapy of Tumours with 15 laboratories
The centre daily provides high-tech oncological care based on the best world standards, using numerous innovative and unique technologies to save patients.
There centre is home to eight departments of medical academies and universities.
The centre’s main activities include:
• Providing highly professional medical care to patients with malignant neoplasms and precancerous conditions;
• Conducting scientific research to study the biology of tumour cells and the mechanisms of carcinogenesis and tumour progression (molecular, virological, chemical, physical, genetic, cellular, and immunological aspects);
• Experimental and clinical development of new technologies for the surgical treatment of malignant tumours;
• Developing new diagnostic tools and methods, drug, radiation, and combination therapy, as well as active tumour prevention;
• Studying diagnostic, treatment, and prevention issues in paediatric oncology;
• Studying the epidemiology of malignant tumours and improving oncological statistics methods;
• Developing a national cancer screening programme together with preventive medicine specialists;
• Scheduling and holding telemedicine consultations in the following fields: oncology, radiotherapy, radiology, pathological anatomy, cytology, immunology, and paediatric oncology, among others;
• Handling the methodological management of Russia’s oncology service and drafting clinical recommendations, procedures, and standards for the provision of oncological care together with the professional community and the Ministry of Health of the Russian Federation;
• Incorporating new devices and technologies into the diagnostic and treatment process and to prevent malignant neoplasms;
• Training scientific and medical personnel through residency, postgraduate studies, and doctoral studies and in the continuing professional education system.
Ivan Stilidi, Chief Visiting Oncologist, Ministry of Health of the Russian Federation; Director, Blokhin National Medical Research Centre of Oncology of the Ministry of Health of the Russian Federation; Doctor of Medical Sciences; Professor; Academician, Russian Academy of Sciences
The Durnov Research Institute of Paediatric Oncology and Haematology is a major paediatric oncology and haematology clinic. It combines the leading achievements of surgical and medicinal treatment of children. The clinic is a leader in cell therapy. Each year, more than 1,200 primary patients are admitted to the research institute, while the number of patients treated exceeds 8,000. The clinic annually performs up to 200 bone marrow transplants. The clinic is unique in terms of many of its technologies (organ-preserving treatment, high-dose therapy).
Route:
Presentation of information about the Blokhin National Medical Research Centre of Oncology and the Durnov Research Institute of Paediatric Oncology and Haematology on the 1st floor (hall)
Visit to the Resuscitation and Intensive Care Unit (5th floor, elevator)
Visit to the Early Childhood Unit (3rd floor, elevator)
Visit to the school of the ‘Learn and Know’ project
Return to the 1st floor hall
All participants need lists in advance.
Foreign citizens need to submit their full name, place of work, and copies of their passports for approval in the security departments a week in advance.
All participants must have a passport with them.
Blokhin National Medical Research Centre of Oncology of the Ministry of Health of the Russian Federation is the largest oncology clinic in Russia and Europe and one of the largest oncology clinics in the world. Its arsenal includes the all the latest equipment and advanced techniques for diagnosing and treating cancer.
Our goal is to continuously improve the quality and accessibility of cancer care. To achieve this goal, we are working to improve the medical care system and introduce the latest technologies.
The centre includes five units:
• Trapeznikov Research Institute of Clinical Oncology with 900 beds
• Research Institute of Paediatric Oncology and Haematology with 299 beds
• Research Institute of Clinical and Experimental Radiology with 101 beds
• Research Institute of Carcinogenesis with 16 laboratories
• Research Institute for Experimental Diagnostics and Therapy of Tumours with 15 laboratories
The centre daily provides high-tech oncological care based on the best world standards, using numerous innovative and unique technologies to save patients.
There centre is home to eight departments of medical academies and universities.
The centre’s main activities include:
• Providing highly professional medical care to patients with malignant neoplasms and precancerous conditions;
• Conducting scientific research to study the biology of tumour cells and the mechanisms of carcinogenesis and tumour progression (molecular, virological, chemical, physical, genetic, cellular, and immunological aspects);
• Experimental and clinical development of new technologies for the surgical treatment of malignant tumours;
• Developing new diagnostic tools and methods, drug, radiation, and combination therapy, as well as active tumour prevention;
• Studying diagnostic, treatment, and prevention issues in paediatric oncology;
• Studying the epidemiology of malignant tumours and improving oncological statistics methods;
• Developing a national cancer screening programme together with preventive medicine specialists;
• Scheduling and holding telemedicine consultations in the following fields: oncology, radiotherapy, radiology, pathological anatomy, cytology, immunology, and paediatric oncology, among others;
• Handling the methodological management of Russia’s oncology service and drafting clinical recommendations, procedures, and standards for the provision of oncological care together with the professional community and the Ministry of Health of the Russian Federation;
• Incorporating new devices and technologies into the diagnostic and treatment process and to prevent malignant neoplasms;
• Training scientific and medical personnel through residency, postgraduate studies, and doctoral studies and in the continuing professional education system.
Ivan Stilidi, Chief Visiting Oncologist, Ministry of Health of the Russian Federation; Director, Blokhin National Medical Research Centre of Oncology of the Ministry of Health of the Russian Federation; Doctor of Medical Sciences; Professor; Academician, Russian Academy of Sciences
